Publications by authors named "Thomas Pires"

Claim this Profile
S
Stool Screening for Campylobacter Species in Hypogammaglobulinemic Patients Receiving Immunoglobulin Therapy.
Basile Mechernene, Philippe Lehours, Etienne Rivière, Noémie Gensous, Claire Tinévez, Thomas Pires

J Clin Immunol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxicity of lanthanum and yttrium oxide nanoparticles and bulk forms on : a study of single mixture exposures.
Joana Santos, Ana Capitão, Manuel Barbosa, Thomás Pires, Edgar Pinto

Nanotoxicology· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substrate interactions guide cyclase engineering and lasso peptide diversification.
Susanna E Barrett, Song Yin, Peter Jordan, John K Brunson, Jessica Gordon-Nunez, Thomas A Pires

Nat Chem Biol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SGN-CD228A Is an Investigational CD228-Directed Antibody-Drug Conjugate with Potent Antitumor Activity across a Wide Spectrum of Preclinical Solid Tumor Models.
Rebecca Mazahreh, Marsha L Mason, John J Gosink, Devra J Olson, Robert Thurman, Thomas A Pires

Mol Cancer Ther· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improving Antibody-Tubulysin Conjugates through Linker Chemistry and Site-Specific Conjugation.
Joseph Z Hamilton, Thomas A Pires, Jamie A Mitchell, Julia H Cochran, Kim K Emmerton

ChemMedChem· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characteristics and risk factors for poor outcome in patients with systemic vasculitis involving the gastrointestinal tract.
Ségolène Gendreau, Raphael Porcher, Benjamin Thoreau, Romain Paule, François Maurier, Thomas Pires

Semin Arthritis Rheum· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Glucuronide-Linked Antibody-Tubulysin Conjugates Display Activity in MDR and Heterogeneous Tumor Models.
Patrick J Burke, Joseph Z Hamilton, Thomas A Pires, Holden W H Lai, Christopher I Leiske

Mol Cancer Ther· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Cationic Proteins on Gold Nanoparticle/Aptamer Assays.
Thomas A Pires, Conor M Narovec, Rebecca J Whelan

ACS Omega· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of Novel Quaternary Ammonium Linkers for Antibody-Drug Conjugates.
Patrick J Burke, Joseph Z Hamilton, Thomas A Pires, Jocelyn R Setter, Joshua H Hunter

Mol Cancer Ther· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis